NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-221-2001-0-PCT-02 PATE, A Gene Expressed in Prostate Cancer, Prostate And Testis, And Uses Thereof PCT PCT PCT/US02/19086 Expired
NCI E-175-2002-0-US-01 METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL ANION DONORS US 60/388,819 Abandoned
NIAID E-131-2002-0-HK-09 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS HK National Stage 05112119.6 Abandoned
NIAID E-131-2002-0-CA-03 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS CA National Stage 2489540 Abandoned
NIEHS E-163-2002-1-US-01 Compositons And Methods For Diagnostics And Therapeutics For Hydrocephalus US 60/388,266 Abandoned
NIEHS E-183-1999-0-US-07 HUMAN P53 MUTATION AND A GENETIC SYSTEM IN YEAST FOR FUNCTIONAL IDENTI FICATION OF HUMAN P53 MUTATIONS US National Stage 10/048,502 7256260 Abandoned PDF
NIMH E-079-2001-0-PCT-02 Use of The Parathyroid Hormone-2(PTH2) Receptor to Screen For Agents to Treat Pain PCT PCT PCT/US02/18771 Expired
NHLBI E-265-2000-0-US-02 MAMMALIAN POLYPEPTIDES AND POLYNUCLEOTIDES US CON 10/183,039 Abandoned
NCI E-033-1999-0-US-03 High Speed Parallel Molecular Nucleic Acid Sequencing US National Stage 10/070,053 6982146 Abandoned PDF
NCI E-135-2002-0-US-01 NOVEL ANTI-CD30 RECOMBINANT IMMUNOTOXINS CONTAINING DISULFIDE- STABILIZED FV FRAGMENTS US 60/387,293 Abandoned
NCI E-055-2002-0-US-01 Novel stable anti-CD22 antibodies US 60/387,306 Abandoned
NHGRI E-167-2001-2-US-01 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium US CIP 11/162,796 Expired
NICHD E-010-1998-1-AU-03 The Protein Tyrosine Kinase Substrate LAT and Its Use in the Identification of (Ant) Agonists of the Kinase AU DIV 45788/02 Abandoned
NCI E-063-2002-0-US-01 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME US 60/385,371 Abandoned
NHGRI E-324-2001-1-US-01 SELECTIONS OF GENES AND METHODS OF USING THE SAME FOR DIAGNOSIS AND FOR TARGETING THE THERAPY OF SELECT CANCERS US CIP 10/159,563 7655397 Abandoned PDF
NCI E-148-1998-1-JP-07 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes JP National Stage 2003-502211 Abandoned
NCI E-148-1998-1-AU-08 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes AU National Stage 2002303934 Abandoned
NCI E-148-1998-1-PCT-02 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes PCT PCT PCT/US2002/017258 Expired
NCI E-148-1998-1-EP-06 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes EP National Stage 02732000.1 Abandoned
NCI E-190-2002-0-US-01 Identification of a Novel BHD Gene US 60/385,181 Abandoned
NICHD E-147-1996-5-CN-09 Use of ADNF-For Enhancing Learning and Memory CN National Stage 01810354.5 Abandoned
NCI E-148-1998-1-CA-05 Molecular Clones with Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes CA National Stage 2448444 Abandoned
NIDDK E-323-2002-0-US-03 Methods for Controlling Intraocular Pressure US National Stage 10/009,581 Expired
NICHD E-355-2003-1-US-01 Antileishmanial Sulfonamide Componds With Activity Against Parasite Tubulin US 60/382,965 Abandoned
NHLBI E-166-2000-0-NZ-09 Nucleic Acids And Proteins of The Human ABCI Gene And Their Therapeutic And Disgnostic Application NZ National Stage 519143 Abandoned
NIAID E-120-2001-0-CA-99 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES CA DIV 3060687 Expired
NIAID E-120-2001-1-BR-02 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses BR DIV BR1220190261547 Expired
NIAID E-120-2001-0-BR-07 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses BR National Stage PI0209943-8 Expired
NIAID E-120-2001-0-CA-87 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES CA DIV 2966716 Expired
NIAID E-120-2001-0-EP-85 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses EP DIV 15150784.5 Expired
NIAID E-120-2001-0-CA-20 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES CA DIV 2755964 Expired
NIAID E-120-2001-0-NL-79 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses NL EP 10181804.5 Expired
NIAID E-120-2001-0-GB-75 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses GB EP 10181804.5 Expired
NIAID E-120-2001-0-CH-71 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses CH EP 10181804.5 Expired
NIAID E-120-2001-0-TR-81 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses TR EP 10181804.5 Expired
NIAID E-120-2001-0-ES-72 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses ES EP 10181804.5 Expired
NIAID E-120-2001-0-SE-80 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses SE EP 10181804.5 Expired
NIAID E-120-2001-0-DE-82 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses DE EP 10181804.5 Expired
NIAID E-120-2001-0-DK-83 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses DK EP 10181804.5 Expired
NIAID E-120-2001-0-FI-73 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses FI EP 10181804.5 Expired
NIAID E-120-2001-0-FR-74 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses FR EP 10181804.5 Expired
NIAID E-120-2001-0-AT-69 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses AT EP 10181804.5 Expired
NIAID E-120-2001-0-BE-70 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses BE EP 10181804.5 Expired
NIAID E-120-2001-0-IT-77 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IT EP 10181804.5 Expired
NIAID E-120-2001-0-IE-76 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IE EP 10181804.5 Expired
NIAID E-120-2001-0-LI-78 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses LI EP 10181804.5 Expired
NIAID E-120-2001-0-EP-17 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses EP DIV 10181804.5 Expired
NIAID E-120-2001-0-EP-16 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses EP DIV 10181786.4 Expired
NIAID E-120-2001-0-LI-65 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses LI EP 10181786.4 Expired
NIAID E-120-2001-0-TR-68 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses TR EP 10181786.4 Expired